Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Gossamer Bio, Inc. | 0 | reported | 19 Mar 2026 | tx 65+7,548,896−3,785,351 |
| Protagonist Therapeutics, Inc | 0 | reported | 08 May 2026 | tx 22+228,871−95,130 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
2 purchases reported after at least 12 months of silence — most recent on 15 Jul 2022.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | EXERCISE | Protagonist Therapeutics, Inc | 24,000 | 6.45 USD | |
| 07 May 2026 | EXERCISE | Protagonist Therapeutics, Inc | 12,000 | 6.98 USD | |
| 07 May 2026 | SALE | Protagonist Therapeutics, Inc | 36,000 | 100.14 USD | |
| 07 May 2026 | SALE | Protagonist Therapeutics, Inc | 12,000 | 100.07 USD | |
| 08 May 2026 | SALE | Protagonist Therapeutics, Inc | 6,000 | 100.00 USD | |
| 08 May 2026 | SALE | Protagonist Therapeutics, Inc | 5,130 | 100.00 USD | |
| 07 May 2026 | EXERCISE | Protagonist Therapeutics, Inc | 24,000 | 0.00 USD | deriv |
| 07 May 2026 | EXERCISE | Protagonist Therapeutics, Inc | 12,000 | 0.00 USD | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 693,750 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 638,000 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 543,750 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 181,250 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 211,500 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 211,500 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 176,667 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 100,000 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 60,000 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 47,667 | — | deriv |
| 19 Mar 2026 | OTHER | Gossamer Bio, Inc. | 96,667 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | Gossamer Bio, Inc. | 693,750 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | Gossamer Bio, Inc. | 638,000 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | Gossamer Bio, Inc. | 543,750 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | Gossamer Bio, Inc. | 181,250 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | Gossamer Bio, Inc. | 211,500 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | Gossamer Bio, Inc. | 211,500 | — | deriv |